chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Incorrect dose administered, Insomnia, No adverse event
Clinical narrative: No adverse event.   Original vaccination was Janssen vaccine on 3/8/2021.  Patient came for a Moderna Booster (.25ml dose) but instead received a full does of Moderna (.5ml). Patient is NOT immunocompromised.  Followed up with patient the following day of vaccination and he reported the night of vaccination he could not sleep, and sweating, which are all listed side effects of Moderna.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Incorrect dose administered, Malaise
Clinical narrative: Patient was given 0.5ml instead of 0.25ml for booster 3rd dosage, patient called on 1/19/2022 and  stated she was weak, sick for a couple of days but fine and manageable, no other problems since 2 days after vaccinations. Letter was sent to patient with dosage given.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Hospitalized with breakthrough COVID infection
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest discomfort, Complex regional pain syndrome, Diarrhoea, Fatigue
Clinical narrative: I had a medical reaction to the first shot of the covid  vaccine. I was seen in my pcp office short!y afterwards and my symptoms were pain in my arms, legs, hands and feet; nausea and vomiting; chest tightness, diarrhea, headache, muscle weakness, fatigue, and joint pain. I have a history of DVT so I chose the Moderna for that reason. I have been struggling with this ever since and now I have been diagnosed with CRPS. I can hardly walk and now I have been out of work for a few weeks.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Headache, Impaired work ability, Laboratory test normal, Muscular weakness
Clinical narrative: I had a medical reaction to the first shot of the covid  vaccine. I was seen in my pcp office short!y afterwards and my symptoms were pain in my arms, legs, hands and feet; nausea and vomiting; chest tightness, diarrhea, headache, muscle weakness, fatigue, and joint pain. I have a history of DVT so I chose the Moderna for that reason. I have been struggling with this ever since and now I have been diagnosed with CRPS. I can hardly walk and now I have been out of work for a few weeks.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Swelling, Vomiting
Clinical narrative: I had a medical reaction to the first shot of the covid  vaccine. I was seen in my pcp office short!y afterwards and my symptoms were pain in my arms, legs, hands and feet; nausea and vomiting; chest tightness, diarrhea, headache, muscle weakness, fatigue, and joint pain. I have a history of DVT so I chose the Moderna for that reason. I have been struggling with this ever since and now I have been diagnosed with CRPS. I can hardly walk and now I have been out of work for a few weeks.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose normal, Cold sweat, Dizziness, Electrocardiogram, Feeling hot
Clinical narrative: Patient reported feeling lightheaded a few minutes after vaccine was administered. Also became hot and clammy. BP taken x 2, and noted to be hypertensive at 182/118. Supervisor and local paramedics notified. 12 lead EKG performed by arriving paramedics, as well as a blood sugar; which was 172. Patient decided to seek additional medical attention and local hospital.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension
Clinical narrative: Patient reported feeling lightheaded a few minutes after vaccine was administered. Also became hot and clammy. BP taken x 2, and noted to be hypertensive at 182/118. Supervisor and local paramedics notified. 12 lead EKG performed by arriving paramedics, as well as a blood sugar; which was 172. Patient decided to seek additional medical attention and local hospital.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred, Vitreous floaters
Clinical narrative: When sitting in front of a computer, patient noticed she found the vision became blurred for about 10 minutes along with floaters in the vision.  After such time, there was full resolution of symptoms.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Chills, Decreased appetite, Dyspnoea, Injection site pain
Clinical narrative: Day of injection: Shivering/shaking, fever, arm pain at site of injection, nausea, lack of appetite  Day 1-14: severe chest pain, difficulty breathing, arm pain at site of injection  Month 0-4 (Sept2021-Jan2022): continued chest pain that is enhanced by any form of exercise, arm pain at the site of injection
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Tremor
Clinical narrative: Day of injection: Shivering/shaking, fever, arm pain at site of injection, nausea, lack of appetite  Day 1-14: severe chest pain, difficulty breathing, arm pain at site of injection  Month 0-4 (Sept2021-Jan2022): continued chest pain that is enhanced by any form of exercise, arm pain at the site of injection
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Pain in extremity
Clinical narrative: Patient was expecting to receive a Moderna Booster (.25ml) but received a full dose (.5ml) of Moderna. Patient is NOT immunocompromised.  Patient had completed pfizer series over 5 months prior.   Followed up with patient and he only reported a sore arm.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: On 1/10/22 patient did not receive COVID-19 Moderna booster as requested and was injected with empty syringe in error.  Patient was followed up with and received correct COVID-19 Moderna vaccine booster on date entered.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Autopsy, Death
Clinical narrative: Passed away on January 31, 2022.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site pain
Clinical narrative: Passed away on January 31, 2022.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, Fatigue, Pain, Pharyngeal erythema
Clinical narrative: I was not feeling bad at all. I had a Covid test on 23rd because I was exposed on December 19, 2021 between 07:30AM and 12:15PM and I tested 08:30 morning of the 23rd at 1pm. I got a positive result then at 3:00pm, I had major fatigue, redness of throat, and body aches. I didn't have any temperature or other symptoms. I did call my doctor (via Facetime). I was advised to seek treatment if I felt I needed to. He only advised to take medications if I had issues or symptoms got worse and what to take OTC but I never had to take any.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I was not feeling bad at all. I had a Covid test on 23rd because I was exposed on December 19, 2021 between 07:30AM and 12:15PM and I tested 08:30 morning of the 23rd at 1pm. I got a positive result then at 3:00pm, I had major fatigue, redness of throat, and body aches. I didn't have any temperature or other symptoms. I did call my doctor (via Facetime). I was advised to seek treatment if I felt I needed to. He only advised to take medications if I had issues or symptoms got worse and what to take OTC but I never had to take any.
Age: 19.0
Sex: F
Vaccine: DTAP
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: 2 hours after the dtap Booster) she is 19 and had received her TDap as an infant ) she started to itch ALL over her body. she thought it was something like her lotion but later on she took a shower to try and calm the itch down as it was getting worse, she managed to fall asleep but woke up to hives EVERYWHERE ON HER BODY , INCLUDING HER GROIN AND FACE AND SCALP, AND WELTED UP ON MOST OF HER SKIN, WITH INSESANT ITCHING. ALSO COMPLETELY RED WITH THE WELTS ON TOP OF HER REDNESS. its now 3 weeks later and she still has hives, she is taking ALEGRA and a prescription antihistamine aswell. we go back to the doctors on the 24th of February 2022
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Injection site pain, Motion sickness
Clinical narrative: First two day: Fever, headache, chills, nausea, dizziness, injection site pain  Next 14 days: Motion sickness when riding in cars and extreme headache (like an ice cream headache) when sitting for longer than 1 minute or standing longer than 3 minutes. Treatment was 800 mg Ibuprofen 3 times per day for 10 days, then 800 mg Ibuprofen twice per day for 4 days, then 800 mg Ibuprofen as needed.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: First two day: Fever, headache, chills, nausea, dizziness, injection site pain  Next 14 days: Motion sickness when riding in cars and extreme headache (like an ice cream headache) when sitting for longer than 1 minute or standing longer than 3 minutes. Treatment was 800 mg Ibuprofen 3 times per day for 10 days, then 800 mg Ibuprofen twice per day for 4 days, then 800 mg Ibuprofen as needed.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient received 0.5 ml of Moderna Booster.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: Period events out of range: January 21-24, February 1- Last period previous vaccination was January 11-13
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Menstruation irregular
Clinical narrative: Heavy menstrual bleeding and irregular periods
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Anticoagulant therapy, Atrial fibrillation, COVID-19, Dyspnoea
Clinical narrative: Patient is fully vaccinated. Admitted with SOB, fall, hypoxia, COVID-19 and AFib with RVR. Treatment: IV Solu-Medrol, Breo inhaler daily, steroids, Eliquis B.I.D., Patient is on remdesivir. Hypokalemia, electrolyte replacement protocol. AKI (acute kidney injury). metoprolol and Eliquis. She medically improved throughout her stay and she was deemed stable for discharge.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Electrolyte substitution therapy, Fall, Hypokalaemia, Hypoxia
Clinical narrative: Patient is fully vaccinated. Admitted with SOB, fall, hypoxia, COVID-19 and AFib with RVR. Treatment: IV Solu-Medrol, Breo inhaler daily, steroids, Eliquis B.I.D., Patient is on remdesivir. Hypokalemia, electrolyte replacement protocol. AKI (acute kidney injury). metoprolol and Eliquis. She medically improved throughout her stay and she was deemed stable for discharge.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Underage before the 5/12 approval for Pfizer vaccine Suspected falsification of DOB ? unable to contact guardian
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Interchange of vaccine products, Periarthritis, Shoulder injury related to vaccine administration, X-ray normal
Clinical narrative: First booster shot after receiving J and  J.  Shoulder started hurting and continually got worse until I needed to see an orthopedic doc.  Diagnosed with SIRVA-----frozen shoulder.  Got two steriod shots and referred to PT
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: On 1/10/22 patient did not receive COVID-19 Moderna booster as requested and was injected with empty syringe in error.  Patient was followed up with and received correct COVID-19 Moderna vaccine booster on date entered.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus.
Age: 14.0
Sex: F
Vaccine: HEP, HEPA, HPV9
Symptoms: Malaise, Syncope
Clinical narrative: Patient received HPV, hepatitis A, and  hepatitis B vaccines. Was educated about dizziness or fainting feeling potentially after HPV vaccine. Patient walked to checkout desk with mom. Patient stated to mom that she was not feeling well and fainted. Desk staff alerted nursing who alerted the providers as well. Patient did not hit head. Was positioned to her back and legs lifted. Eventually moved to room where vital signs were taken and she was given apple juice and graham crackers. Physician evaluated patient and found patient was safe to go home. No injuries found.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chemotherapy, Marginal zone lymphoma, SARS-CoV-2 test positive
Clinical narrative: Received Moderna vaccines on 1/27, 2/24, 12/28/21 COVID-19 positive by PCR on  1/31/22 admitted to hospital on 1/31/22 w/ COVID pneumonia. underlying recent diagnosis of marginal zone lymphoma, received cycle 1 of chemo on 1/18/22.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient was given 0.5 ml instead of 0.25mg booster vaccine 3rd dosage, and patient was called on 1/19/2022 and denies any problems since vaccination. A letter was sent to patient informing of dosage given.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was given one day past BUD.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash of Upper arm
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory distress syndrome, Acute respiratory failure, Angiogram pulmonary abnormal, Blood culture positive
Clinical narrative: Patient is DECEASED (2.1.22);  Hospitalized 1.22.22 - 2.1.22;  COVID-19 positive (1.19.22); fully vaccinated (no booster) Admission Date: 1/27/2022 (to higher level of care; moved from HCF to another Hospital ICU) Date of Death: 2/1/22 Time of Death:  1:11 PM Preliminary Cause of Death: Pneumonia due to COVID-19 virus DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory distress syndrome (ARDS) due to COVID-19 virus (HCC)  HOSPITAL COURSE: 53yo with history of asthma, HTN, and morbid obesity (BMI 55). Single dose of J+J COVID vaccine received in May 2021.  He was found to be COVID+ 1/19 and was admitted 1/22 to HCF on HFNC. He continued to decompensate and was intubated 1/23. NMB and proning started.  Proning was stopped 1/26 due to severe facial edema. He developed progressive AKI and was transferred to ICU for nephrology consultation and potential need for RRT. PIRRT was started on 1/28. 1/31 developed anisocria, CT head showed severe cerebral edema with diffuse sulcal and basilar cistern effacement, transtentorial herniation, and cerebellar tonsillar herniation.  Neuro ICU consulted. Mild hyperammonemia and low-normal sodium. Multifactorial causation for cerebral edema. Patient was not responsive to any stimuli.  Patient was DNR status, after discussion with family on 2/1, transitioned to comfort care on 2/1. Interventions withdrawn with death shortly afterward at 1:11pm 2/1/2022.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased, Blood sodium decreased, Brain herniation, Brain oedema, COVID-19
Clinical narrative: Patient is DECEASED (2.1.22);  Hospitalized 1.22.22 - 2.1.22;  COVID-19 positive (1.19.22); fully vaccinated (no booster) Admission Date: 1/27/2022 (to higher level of care; moved from HCF to another Hospital ICU) Date of Death: 2/1/22 Time of Death:  1:11 PM Preliminary Cause of Death: Pneumonia due to COVID-19 virus DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory distress syndrome (ARDS) due to COVID-19 virus (HCC)  HOSPITAL COURSE: 53yo with history of asthma, HTN, and morbid obesity (BMI 55). Single dose of J+J COVID vaccine received in May 2021.  He was found to be COVID+ 1/19 and was admitted 1/22 to HCF on HFNC. He continued to decompensate and was intubated 1/23. NMB and proning started.  Proning was stopped 1/26 due to severe facial edema. He developed progressive AKI and was transferred to ICU for nephrology consultation and potential need for RRT. PIRRT was started on 1/28. 1/31 developed anisocria, CT head showed severe cerebral edema with diffuse sulcal and basilar cistern effacement, transtentorial herniation, and cerebellar tonsillar herniation.  Neuro ICU consulted. Mild hyperammonemia and low-normal sodium. Multifactorial causation for cerebral edema. Patient was not responsive to any stimuli.  Patient was DNR status, after discussion with family on 2/1, transitioned to comfort care on 2/1. Interventions withdrawn with death shortly afterward at 1:11pm 2/1/2022.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Cerebral mass effect, Cervical radiculopathy, Computerised tomogram head abnormal, Death
Clinical narrative: Patient is DECEASED (2.1.22);  Hospitalized 1.22.22 - 2.1.22;  COVID-19 positive (1.19.22); fully vaccinated (no booster) Admission Date: 1/27/2022 (to higher level of care; moved from HCF to another Hospital ICU) Date of Death: 2/1/22 Time of Death:  1:11 PM Preliminary Cause of Death: Pneumonia due to COVID-19 virus DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory distress syndrome (ARDS) due to COVID-19 virus (HCC)  HOSPITAL COURSE: 53yo with history of asthma, HTN, and morbid obesity (BMI 55). Single dose of J+J COVID vaccine received in May 2021.  He was found to be COVID+ 1/19 and was admitted 1/22 to HCF on HFNC. He continued to decompensate and was intubated 1/23. NMB and proning started.  Proning was stopped 1/26 due to severe facial edema. He developed progressive AKI and was transferred to ICU for nephrology consultation and potential need for RRT. PIRRT was started on 1/28. 1/31 developed anisocria, CT head showed severe cerebral edema with diffuse sulcal and basilar cistern effacement, transtentorial herniation, and cerebellar tonsillar herniation.  Neuro ICU consulted. Mild hyperammonemia and low-normal sodium. Multifactorial causation for cerebral edema. Patient was not responsive to any stimuli.  Patient was DNR status, after discussion with family on 2/1, transitioned to comfort care on 2/1. Interventions withdrawn with death shortly afterward at 1:11pm 2/1/2022.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Drug abuse, Dyspnoea, Endotracheal intubation, Escherichia test positive, Face oedema
Clinical narrative: Patient is DECEASED (2.1.22);  Hospitalized 1.22.22 - 2.1.22;  COVID-19 positive (1.19.22); fully vaccinated (no booster) Admission Date: 1/27/2022 (to higher level of care; moved from HCF to another Hospital ICU) Date of Death: 2/1/22 Time of Death:  1:11 PM Preliminary Cause of Death: Pneumonia due to COVID-19 virus DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory distress syndrome (ARDS) due to COVID-19 virus (HCC)  HOSPITAL COURSE: 53yo with history of asthma, HTN, and morbid obesity (BMI 55). Single dose of J+J COVID vaccine received in May 2021.  He was found to be COVID+ 1/19 and was admitted 1/22 to HCF on HFNC. He continued to decompensate and was intubated 1/23. NMB and proning started.  Proning was stopped 1/26 due to severe facial edema. He developed progressive AKI and was transferred to ICU for nephrology consultation and potential need for RRT. PIRRT was started on 1/28. 1/31 developed anisocria, CT head showed severe cerebral edema with diffuse sulcal and basilar cistern effacement, transtentorial herniation, and cerebellar tonsillar herniation.  Neuro ICU consulted. Mild hyperammonemia and low-normal sodium. Multifactorial causation for cerebral edema. Patient was not responsive to any stimuli.  Patient was DNR status, after discussion with family on 2/1, transitioned to comfort care on 2/1. Interventions withdrawn with death shortly afterward at 1:11pm 2/1/2022.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperammonaemia, Hypervolaemia, Hypoxia, Intensive care, Mechanical ventilation
Clinical narrative: Patient is DECEASED (2.1.22);  Hospitalized 1.22.22 - 2.1.22;  COVID-19 positive (1.19.22); fully vaccinated (no booster) Admission Date: 1/27/2022 (to higher level of care; moved from HCF to another Hospital ICU) Date of Death: 2/1/22 Time of Death:  1:11 PM Preliminary Cause of Death: Pneumonia due to COVID-19 virus DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory distress syndrome (ARDS) due to COVID-19 virus (HCC)  HOSPITAL COURSE: 53yo with history of asthma, HTN, and morbid obesity (BMI 55). Single dose of J+J COVID vaccine received in May 2021.  He was found to be COVID+ 1/19 and was admitted 1/22 to HCF on HFNC. He continued to decompensate and was intubated 1/23. NMB and proning started.  Proning was stopped 1/26 due to severe facial edema. He developed progressive AKI and was transferred to ICU for nephrology consultation and potential need for RRT. PIRRT was started on 1/28. 1/31 developed anisocria, CT head showed severe cerebral edema with diffuse sulcal and basilar cistern effacement, transtentorial herniation, and cerebellar tonsillar herniation.  Neuro ICU consulted. Mild hyperammonemia and low-normal sodium. Multifactorial causation for cerebral edema. Patient was not responsive to any stimuli.  Patient was DNR status, after discussion with family on 2/1, transitioned to comfort care on 2/1. Interventions withdrawn with death shortly afterward at 1:11pm 2/1/2022.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Pupils unequal, Renal impairment, Renal replacement therapy, Rheumatoid arthritis, SARS-CoV-2 test positive
Clinical narrative: Patient is DECEASED (2.1.22);  Hospitalized 1.22.22 - 2.1.22;  COVID-19 positive (1.19.22); fully vaccinated (no booster) Admission Date: 1/27/2022 (to higher level of care; moved from HCF to another Hospital ICU) Date of Death: 2/1/22 Time of Death:  1:11 PM Preliminary Cause of Death: Pneumonia due to COVID-19 virus DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory distress syndrome (ARDS) due to COVID-19 virus (HCC)  HOSPITAL COURSE: 53yo with history of asthma, HTN, and morbid obesity (BMI 55). Single dose of J+J COVID vaccine received in May 2021.  He was found to be COVID+ 1/19 and was admitted 1/22 to HCF on HFNC. He continued to decompensate and was intubated 1/23. NMB and proning started.  Proning was stopped 1/26 due to severe facial edema. He developed progressive AKI and was transferred to ICU for nephrology consultation and potential need for RRT. PIRRT was started on 1/28. 1/31 developed anisocria, CT head showed severe cerebral edema with diffuse sulcal and basilar cistern effacement, transtentorial herniation, and cerebellar tonsillar herniation.  Neuro ICU consulted. Mild hyperammonemia and low-normal sodium. Multifactorial causation for cerebral edema. Patient was not responsive to any stimuli.  Patient was DNR status, after discussion with family on 2/1, transitioned to comfort care on 2/1. Interventions withdrawn with death shortly afterward at 1:11pm 2/1/2022.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Sputum culture positive, Staphylococcus test positive, Unresponsive to stimuli, Urine output decreased
Clinical narrative: Patient is DECEASED (2.1.22);  Hospitalized 1.22.22 - 2.1.22;  COVID-19 positive (1.19.22); fully vaccinated (no booster) Admission Date: 1/27/2022 (to higher level of care; moved from HCF to another Hospital ICU) Date of Death: 2/1/22 Time of Death:  1:11 PM Preliminary Cause of Death: Pneumonia due to COVID-19 virus DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory distress syndrome (ARDS) due to COVID-19 virus (HCC)  HOSPITAL COURSE: 53yo with history of asthma, HTN, and morbid obesity (BMI 55). Single dose of J+J COVID vaccine received in May 2021.  He was found to be COVID+ 1/19 and was admitted 1/22 to HCF on HFNC. He continued to decompensate and was intubated 1/23. NMB and proning started.  Proning was stopped 1/26 due to severe facial edema. He developed progressive AKI and was transferred to ICU for nephrology consultation and potential need for RRT. PIRRT was started on 1/28. 1/31 developed anisocria, CT head showed severe cerebral edema with diffuse sulcal and basilar cistern effacement, transtentorial herniation, and cerebellar tonsillar herniation.  Neuro ICU consulted. Mild hyperammonemia and low-normal sodium. Multifactorial causation for cerebral edema. Patient was not responsive to any stimuli.  Patient was DNR status, after discussion with family on 2/1, transitioned to comfort care on 2/1. Interventions withdrawn with death shortly afterward at 1:11pm 2/1/2022.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient received 0.5 ml Moderna Booster.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Condition aggravated, Laboratory test, Lymphadenopathy, Migraine
Clinical narrative: 01/21/2022 Friday the night next day 01/22/2022, not able to get out of bed low grade fever 101.8 highest and severe body arches and joint pain, did not notice the dizziness 01/24/2022 Monday, unable to move without extreme nausea, migraine and motion sickness of vertigo. Tele-visit on Tuesday and was given directive of if not better to come to the office. On Friday 01/28/2022, went to doctor office as symptoms was not improving. Prescribed medication that current is not working and contact the doctor on 01/31/2022 and new prescriptions was prescribed and supposed to pick up new medication today. Diagnosed with vertigo and extreme enhanced migraines. Was prescribed exercised for inter ear issue and  the motion system is proving to be difficult in the exercise process. Swollen lymph node under left arm side of vaccination and that occurred with vaccination 1 and two as well 101.8 temp.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Motion sickness, Nausea, Pain, Pyrexia, Vertigo
Clinical narrative: 01/21/2022 Friday the night next day 01/22/2022, not able to get out of bed low grade fever 101.8 highest and severe body arches and joint pain, did not notice the dizziness 01/24/2022 Monday, unable to move without extreme nausea, migraine and motion sickness of vertigo. Tele-visit on Tuesday and was given directive of if not better to come to the office. On Friday 01/28/2022, went to doctor office as symptoms was not improving. Prescribed medication that current is not working and contact the doctor on 01/31/2022 and new prescriptions was prescribed and supposed to pick up new medication today. Diagnosed with vertigo and extreme enhanced migraines. Was prescribed exercised for inter ear issue and  the motion system is proving to be difficult in the exercise process. Swollen lymph node under left arm side of vaccination and that occurred with vaccination 1 and two as well 101.8 temp.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Full blood count normal, Hepatitis C RNA, Hepatitis C RNA negative, Pruritus
Clinical narrative: whole body intense itching without provocation, worst on feet, hands, trunk. scratching produces red wheals. no response to moisturizer. occurs multiple times daily. Use of daily cetirizine reduces symptom frequency and intensity and distribution: feet and abdomen and upper back remain most likely to start itching without provocation.  Patient does not have history of seasonal or food allergies.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Scratch, Treponema test negative, Urticaria
Clinical narrative: whole body intense itching without provocation, worst on feet, hands, trunk. scratching produces red wheals. no response to moisturizer. occurs multiple times daily. Use of daily cetirizine reduces symptom frequency and intensity and distribution: feet and abdomen and upper back remain most likely to start itching without provocation.  Patient does not have history of seasonal or food allergies.
Age: 30.0
Sex: M
Vaccine: UNK
Symptoms: Incorrect dose administered, Syringe issue
Clinical narrative: On 1/10/22 patient did not receive COVID-19 Moderna booster as requested and was injected with empty syringe in error.  Unable to contact patient for follow up. Certified letter sent to patient address on file.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Culture stool, Diarrhoea, Nausea
Clinical narrative: Nausea started following day after vaccination, Dec 14th through present still in affect. Dec 27th severe nausea and diarrhea. Continues now in cycles every 3 to 6 days, lasting 30 to 36 hrs at a time.  Dr requested stool samples for parasites and white blood cell count. G.I. Dr requested more of the same.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dementia with Lewy bodies, Mental status changes, SARS-CoV-2 test positive
Clinical narrative: Received Moderna vaccines on 1/13, 2/12, 11/18/21. COVID-19 positive by PCR on 1/29/22. Admitted to hospital on 1/30/22 d/t altered mental status, COVID-19 infection. Underlying Lewy Body Dementia
Age: 58.0
Sex: U
Vaccine: COVID19
Symptoms: Rash, Rash pruritic, Rash vesicular
Clinical narrative: Rash on both legs that is spreading. Started itchy, now painful and itchy. Now rash appears like a blister.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: General symptom
Clinical narrative: Onset of symptoms 8/16/21
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No, adverse event, no treatment needed. Parent falsified patient age on screening sheet. answer that child was 12. Health services reported today that child was under 12 at the time of first dose.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated, not boosted. COVID breakthrough infection
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Hormone level abnormal, Laboratory test, Menstrual disorder
Clinical narrative: Menstrual Cycle disruption and Hormonal imbalance.
Age: 33.0
Sex: M
Vaccine: UNK
Symptoms: Underdose, Wrong technique in product usage process
Clinical narrative: On 1/10/22 patient did not receive COVID-19 Moderna booster as requested and was injected with empty syringe in error.  Unable to contact patient for follow up. Certified letter sent to patient address on file.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient received 0.5 ml Moderna Booster
Age: 0.58
Sex: M
Vaccine: DTAPHEPBIP, FLU4, PNC13, RV5
Symptoms: Abdominal pain, Diarrhoea haemorrhagic, Intestinal resection, Intussusception, Large intestinal obstruction reduction
Clinical narrative: Patient had colicky abdominal pain and vomiting the week after having immunizations including 2nd dose of RotaTeq.  Symptoms were progressive and patient followed up  with urgent care without appropriate evaluation or treatment.  Patient began to have bilious emesis and bloody diarrhea and so was seen at ED 24 Jan 2022 with US diagnostic for intussusception.   Non operative reduction was unsuccessful and patient required surgery with excision of 5 inches of bowel.
Age: 0.58
Sex: M
Vaccine: DTAPHEPBIP, FLU4, PNC13, RV5
Symptoms: Ultrasound abdomen abnormal, Vomiting
Clinical narrative: Patient had colicky abdominal pain and vomiting the week after having immunizations including 2nd dose of RotaTeq.  Symptoms were progressive and patient followed up  with urgent care without appropriate evaluation or treatment.  Patient began to have bilious emesis and bloody diarrhea and so was seen at ED 24 Jan 2022 with US diagnostic for intussusception.   Non operative reduction was unsuccessful and patient required surgery with excision of 5 inches of bowel.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Cough, Dehydration, Fatigue
Clinical narrative: Patient is fully vaccinated.  COVID + 12/25/2021.  ED visit 1/6/2022.  Chief complaint dehydration. Positive for congestion, cough, fatigue, headaches, weakness, myalgias, nausea.  BP 108/58  | Pulse 73  | Temp 98.9 °F (37.2 °C) (Oral)  | Resp 18  | Ht 157.5 cm (5' 2")  | Wt 45.4 kg (100 lb)  | SpO2 100%  | BMI 18.29 kg/m² Extensive workup otherwise unremarkable - given fluid rehydration, decadron, benadryl and stable for discharge.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea, Respiratory tract congestion
Clinical narrative: Patient is fully vaccinated.  COVID + 12/25/2021.  ED visit 1/6/2022.  Chief complaint dehydration. Positive for congestion, cough, fatigue, headaches, weakness, myalgias, nausea.  BP 108/58  | Pulse 73  | Temp 98.9 °F (37.2 °C) (Oral)  | Resp 18  | Ht 157.5 cm (5' 2")  | Wt 45.4 kg (100 lb)  | SpO2 100%  | BMI 18.29 kg/m² Extensive workup otherwise unremarkable - given fluid rehydration, decadron, benadryl and stable for discharge.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Vomiting
Clinical narrative: Shortly after receiving the vaccine, patient's mom told us patient had vomited a small amount into her mask.  Patient stated she was still nauseous and had a headache and proceeded to vomit again a much larger amount.  After this, she remained in the observation area and did not vomit again and left the pharmacy with mom and dad.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Fibromyalgia
Clinical narrative: Patient states has had an abnormal trigger in fibromyalgia symptoms starting two weeks post dose #1 of vaccine. Patient believes fibromyalgia was doing fine prior to shot, now has tingling feeling down back and arms.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Insomnia, Muscle spasms, Neck pain, Paraesthesia
Clinical narrative: Developed pain in back and neck under 48 hours after infection. This turned into spasms and neck pain, fingers tingling and left arm falls asleep if positioned in certain position. Sleep is uncomfortable
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Cardioversion, Chest pain, Dizziness, Dyspnoea, Electrocardiogram abnormal
Clinical narrative: 10/26/2021 I began to take Ozempic injections once a weak and began taking it on this day. I had severe chest pain and then it went away. That afternoon I had visual disturbance, diaphoresis and it went away. The following week I took a second dose of Ozempic on Nov. 2nd, at night I had severe chest pain tachycardia, chest pain and pain down my left arm. After sitting down it went away. On Nov. 3rd I went to work and as I was sitting down I started feeling like I was going to pass out and went to the ER. EKG at ER showed I was having a heart attack and from further work up found a blood clot that was a 95% blockage. The next evening I was able to get discharged.  Nov. 19th I was having shortness of breath and went back for 5 days and cardioverted me on Nov. 22nd. Symptoms are no longer there and have cleared up since then. I am currently in cardiac rehab as well.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Injection, Myocardial infarction, Pain in extremity, Tachycardia
Clinical narrative: 10/26/2021 I began to take Ozempic injections once a weak and began taking it on this day. I had severe chest pain and then it went away. That afternoon I had visual disturbance, diaphoresis and it went away. The following week I took a second dose of Ozempic on Nov. 2nd, at night I had severe chest pain tachycardia, chest pain and pain down my left arm. After sitting down it went away. On Nov. 3rd I went to work and as I was sitting down I started feeling like I was going to pass out and went to the ER. EKG at ER showed I was having a heart attack and from further work up found a blood clot that was a 95% blockage. The next evening I was able to get discharged.  Nov. 19th I was having shortness of breath and went back for 5 days and cardioverted me on Nov. 22nd. Symptoms are no longer there and have cleared up since then. I am currently in cardiac rehab as well.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Thrombosis, Visual impairment
Clinical narrative: 10/26/2021 I began to take Ozempic injections once a weak and began taking it on this day. I had severe chest pain and then it went away. That afternoon I had visual disturbance, diaphoresis and it went away. The following week I took a second dose of Ozempic on Nov. 2nd, at night I had severe chest pain tachycardia, chest pain and pain down my left arm. After sitting down it went away. On Nov. 3rd I went to work and as I was sitting down I started feeling like I was going to pass out and went to the ER. EKG at ER showed I was having a heart attack and from further work up found a blood clot that was a 95% blockage. The next evening I was able to get discharged.  Nov. 19th I was having shortness of breath and went back for 5 days and cardioverted me on Nov. 22nd. Symptoms are no longer there and have cleared up since then. I am currently in cardiac rehab as well.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Underage before the 5/12/21  approval for Pfizer vaccine  Guardian elected to falsify DOB
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: General symptom
Clinical narrative: Onset of symptoms 10/12/2021.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Cardiac ventricular thrombosis, Death, Flank pain, Renal vascular thrombosis
Clinical narrative: Patient started complaining of hurting in his side (I don't remember if it was left or right) on Wednesday Sept. 15, 2021 and he thought maybe he had strained a muscle.  The pain grew worse and moved up his body until on Sunday morning Sept. 19th he drove himself to the emergency department because the pain was so intense it was unbearable.  The doctors discovered his spleen was full of blood cots, also the upper left ventricle of his heart had blood clots, his kidneys and pretty much from what I understood they were throughout his body.  He was in the hospital until Sept. 24th I believe and was discharged.  They discharged him on Xarelto and he was to come back but he came to our house in another state and we went to a cardiologist.  He didn't have insurance and was going to get it but it wouldn't be good until Jan. 01, 2022 so the doctor told him to call and schedule and appointment the first week of Jan. 2022 and they would do some procedures, check on the status of the blood clots and kept him on all his meds and the Xarelto but my son passed on November 25, 2021.  Had he been an illegal alien he would have been given treatment immediately with no concerns of not having insurance.   I'm furious!!!
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Splenic thrombosis, Thrombosis
Clinical narrative: Patient started complaining of hurting in his side (I don't remember if it was left or right) on Wednesday Sept. 15, 2021 and he thought maybe he had strained a muscle.  The pain grew worse and moved up his body until on Sunday morning Sept. 19th he drove himself to the emergency department because the pain was so intense it was unbearable.  The doctors discovered his spleen was full of blood cots, also the upper left ventricle of his heart had blood clots, his kidneys and pretty much from what I understood they were throughout his body.  He was in the hospital until Sept. 24th I believe and was discharged.  They discharged him on Xarelto and he was to come back but he came to our house in another state and we went to a cardiologist.  He didn't have insurance and was going to get it but it wouldn't be good until Jan. 01, 2022 so the doctor told him to call and schedule and appointment the first week of Jan. 2022 and they would do some procedures, check on the status of the blood clots and kept him on all his meds and the Xarelto but my son passed on November 25, 2021.  Had he been an illegal alien he would have been given treatment immediately with no concerns of not having insurance.   I'm furious!!!
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Seizure
Clinical narrative: seizure
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Ultrasound scan
Clinical narrative: spontaneous DVT confirmed with US
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Eye movement disorder
Clinical narrative: Patients head tilted back and eyes were rolled up, towards the top. She appeared clammy and remained conscious. Patient did not want to discuss past medical history but stated this has happened before when she received previous vaccines. Patient quickly returned to normal state. Vital signs were taken and she was offered water.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal discomfort, Musculoskeletal stiffness
Clinical narrative: Left shoulder not functioning like before. Almost stiff.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Client died 9 months later
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given 0.5ml instead of 0.25ml booster vaccine, patient was called on 1/19/2022 and denies any problems since vaccination. Letter sent to patient informing of dosage given.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: General symptom
Clinical narrative: Onset of symptoms 10/20/2021.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient received 0.5mL Moderna booster.
Age: 23.0
Sex: F
Vaccine: HEP
Symptoms: Expired product administered, No adverse event
Clinical narrative: Hepatitis B vaccine that was given to patient on 1/24/22 expired on 12/6/21.  There were no know signs or symptoms reported by the patient or seen by the staff as a result of vaccine administration.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated, not boosted.   COVID breakthrough infection
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: General symptom
Clinical narrative: Onset of symptoms 10/20/21
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination error
Clinical narrative: Vaccination Error
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Unknown
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Underage before the 5/12 approval for Pfizer vaccine, Suspected falsification of DOB ? guardian ?unsure? how DOB error occurred
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, COVID-19 pneumonia, Death, Diastolic dysfunction, Dyspnoea
Clinical narrative: recently dc'd from hosp for COVID pneumonia and hypoxic respiratory failure to SNF; on 3 L O2 via NC; began to have worsening SOB and hypoxia; placed on NRB mask with O2 sats improvement between 80-96%; EMS contacted and transported to ED; in ED pt experienced A Fib with rapid Ventricular response; Cardizem given; transferred to ICU; fluid overload due to diastolic dysfunction; COVID fibrosis; treated with steroids and antibiotics; pt's condition worsened; family transitioned pt to comfort care and he passed away in the hosp
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrosis, Hypervolaemia, Hypoxia, Intensive care, Respiratory failure
Clinical narrative: recently dc'd from hosp for COVID pneumonia and hypoxic respiratory failure to SNF; on 3 L O2 via NC; began to have worsening SOB and hypoxia; placed on NRB mask with O2 sats improvement between 80-96%; EMS contacted and transported to ED; in ED pt experienced A Fib with rapid Ventricular response; Cardizem given; transferred to ICU; fluid overload due to diastolic dysfunction; COVID fibrosis; treated with steroids and antibiotics; pt's condition worsened; family transitioned pt to comfort care and he passed away in the hosp
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance, Hypoaesthesia, Muscle twitching
Clinical narrative: Pt.'s Wife states that after receiving the 2nd dose of Moderna 04/11/2021, started experiencing symptoms 04/17/2021 of right knee pain with difficulty walking, hand numbness in the left hand, and a "twitch" in the mouth. No noted Primary visit/communications.
Age: 24.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asymptomatic COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated and boosted.   COVID breakthrough infection, asymptomatic
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: C-reactive protein increased, Chest X-ray abnormal, Chest discomfort, Cough, Dyspnoea
Clinical narrative: Patient received 1st covid vaccine on 2/16/21 and the 2nd dose on 3/16/21. Patient presented to outside hospital on 10/6/21 with worsening cough, SOB and chest pressure that started since July 2021 found to have large L pleural effusion and moderate pericardial effusion. She had signs of systemic inflammation with a leukocytosis to 17.6, D-dimer of 2500, ESR of 101, and CRP of 250. Patient was covid negative. Chest x ray demonstrated a left sided moderate pleural effusion with retrocardiac opacity and moderate pulmonary interstitial edema. EKG re demonstrated the moderate circumferential pericardial effusion with consolidated appearance and no evidence of tamponade. Patient received cardiac mri on 12/10/21 as an outpatient and below is the conclusion. 1.  There is mild thickening and late gadolinium enhancement of the pericardium, likely representing ongoing pericardial inflammation. No pericardial edema to indicate acute pericarditis. Interval resolution of pericardial effusion. No evidence of pericardial constriction. 2.  Conglomerate of lymph nodes in the right anterior mediastinum which is decreased in size slightly compared with prior imaging may be reactive. This can be reassessed with contrast enhanced CT chest in 2-3 months. 3.  Small left pleural effusion with interval decrease in size.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Fibrin D dimer increased, Inflammation, Leukocytosis, Lung opacity
Clinical narrative: Patient received 1st covid vaccine on 2/16/21 and the 2nd dose on 3/16/21. Patient presented to outside hospital on 10/6/21 with worsening cough, SOB and chest pressure that started since July 2021 found to have large L pleural effusion and moderate pericardial effusion. She had signs of systemic inflammation with a leukocytosis to 17.6, D-dimer of 2500, ESR of 101, and CRP of 250. Patient was covid negative. Chest x ray demonstrated a left sided moderate pleural effusion with retrocardiac opacity and moderate pulmonary interstitial edema. EKG re demonstrated the moderate circumferential pericardial effusion with consolidated appearance and no evidence of tamponade. Patient received cardiac mri on 12/10/21 as an outpatient and below is the conclusion. 1.  There is mild thickening and late gadolinium enhancement of the pericardium, likely representing ongoing pericardial inflammation. No pericardial edema to indicate acute pericarditis. Interval resolution of pericardial effusion. No evidence of pericardial constriction. 2.  Conglomerate of lymph nodes in the right anterior mediastinum which is decreased in size slightly compared with prior imaging may be reactive. This can be reassessed with contrast enhanced CT chest in 2-3 months. 3.  Small left pleural effusion with interval decrease in size.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy mediastinal, Magnetic resonance imaging heart, Pericardial effusion, Pericardial fibrosis, Pericarditis
Clinical narrative: Patient received 1st covid vaccine on 2/16/21 and the 2nd dose on 3/16/21. Patient presented to outside hospital on 10/6/21 with worsening cough, SOB and chest pressure that started since July 2021 found to have large L pleural effusion and moderate pericardial effusion. She had signs of systemic inflammation with a leukocytosis to 17.6, D-dimer of 2500, ESR of 101, and CRP of 250. Patient was covid negative. Chest x ray demonstrated a left sided moderate pleural effusion with retrocardiac opacity and moderate pulmonary interstitial edema. EKG re demonstrated the moderate circumferential pericardial effusion with consolidated appearance and no evidence of tamponade. Patient received cardiac mri on 12/10/21 as an outpatient and below is the conclusion. 1.  There is mild thickening and late gadolinium enhancement of the pericardium, likely representing ongoing pericardial inflammation. No pericardial edema to indicate acute pericarditis. Interval resolution of pericardial effusion. No evidence of pericardial constriction. 2.  Conglomerate of lymph nodes in the right anterior mediastinum which is decreased in size slightly compared with prior imaging may be reactive. This can be reassessed with contrast enhanced CT chest in 2-3 months. 3.  Small left pleural effusion with interval decrease in size.